I don’t work on CAR-T cells myself but lots of people in my lab do. They are a really exciting new strategy for cancer immunotherapy. The process involves four steps: 1) extract a patient’s own “killer” white blood cells; 2) edit the genes so that these cells become targeted to the patient’s cancer; 3) grow the cells in a petri dish until you have loads of them; 4) inject them back into the patient. The engineered T cells then find the patient’s cancer and attack it.
We’re trying to improve step 2 – making the editing process safer and faster. It’s really exciting work!
I have worked with a company that make CAR-T cell therapy and it is a very exciting development in the world of medicine. It is quite a complex treatment to explain to people and is also quite expensive but is a one-off treatment that has a high cure rate for some types of cancer, so its an interesting communications challenge.
Comments